Found 17 matching trials
Prospective Multicenter Single-arm Trial: AK112 + Nab-paclitaxel/Carboplatin Neoadjuvant for TNBC
PHASE2This prospective, multicenter, single-arm clinical study aims to evaluate t...
Location
Multiple Locations
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
PHASE2AK112, alone or in combination with chemotherapy for the neoadjuvant/adjuva...
Status
Active Not Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
PHASE2The purpose of this study is to further advance the ability to practice per...
Location
University of Alabama at Birmingham
Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer
PHASE2This study is a multicenter, single-arm, investigator-initiated Phase II cl...
Location
Multiple Locations
Neoadjuvant Angiogenesis-Targeting Bispecific Chemoimmunotherapy for TNBC
PHASE2This study will test the effectiveness of two standard neoadjuvant chemothe...
Location
Multiple Locations
Neoadjuvant Short-Course Radiotherapy With or Without Chemotherapy and AK112 in Locally Advanced Rectal Cancer
PHASE2This phase II multicenter, randomized study evaluates the safety and effica...
Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer
PHASE2This study is a single-arm, prospective, phase II clinical study to evaluat...
Location
Multiple Locations
Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma
PHASE2Study Overview
The primary objective of this clinical trial is to evaluate...
Location
Department of Cancer Medical Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer
PHASE2This is an open label, prospective, single center Phase II clinical study. ...
Location
Multiple Locations